Philadelphia-area firms raised $3.1 billion in venture capital funding during the first half of 2021, already smashing an annual record set two years ago. Interius Biotherapeutics, a Penn Medicine spinout, was one of the firms with a $76 million Series A raise.
Read More in the Philadelphia Business Journal (Might have paywall)